ResMed (RMD) Tops Q4 EPS by 3c, Revenue Beats
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $231.52 +1.35%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $453.1 million versus the consensus estimate of $436.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
